Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Public ClinicalTrials.gov record NCT02336698. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Study identification
- NCT ID
- NCT02336698
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Enrollment
- 18 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Fulranumab 1 mg Drug
- Fulranumab 3 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 12, 2015
- Primary completion
- Sep 14, 2016
- Completion
- Sep 14, 2016
- Last update posted
- Oct 1, 2017
2015 – 2016
United States locations
- U.S. sites
- 26
- U.S. states
- 14
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Costa Mesa | California | — | — |
| Not listed | Laguna Hills | California | — | — |
| Not listed | Lakewood | California | — | — |
| Not listed | Northridge | California | — | — |
| Not listed | Santa Clarita | California | — | — |
| Not listed | Thousand Oaks | California | — | — |
| Not listed | Boynton Beach | Florida | — | — |
| Not listed | Lake Clarke Shores | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Bay City | Michigan | — | — |
| Not listed | Caro | Michigan | — | — |
| Not listed | Grand Rapids | Michigan | — | — |
| Not listed | Somerset | New Jersey | — | — |
| Not listed | Greenville | North Carolina | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | Bedford | Texas | — | — |
| Not listed | Cypress | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Waxahachie | Texas | — | — |
| Not listed | Riverton | Utah | — | — |
| Not listed | Norfolk | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02336698, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 1, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02336698 live on ClinicalTrials.gov.